Acquired palmoplantar keratoderma.
Patel S, Zirwas M, English JC 3rd.
Am J Clin Dermatol. 2007;8(1):1-11. doi: 10.2165/00128071-200708010-00001.
Mal de Meleda.
Ho PY, Lin YT.
JAMA Dermatol. 2024 Apr 1;160(4):464-465. doi: 10.1001/jamadermatol.2024.0117.
ECFS standards of care on CFTR-related disorders: Identification and care of the disorders.
Simmonds NJ, Southern KW, De Wachter E, De Boeck K, Bodewes F, Mainz JG, Middleton PG, Schwarz C, Vloeberghs V, Wilschanski M, Bourrat E, Chalmers JD, Ooi CY, Debray D, Downey DG, Eschenhagen P, Girodon E, Hickman G, Koitschev A, Nazareth D, Nick JA, Peckham D, VanDevanter D, Raynal C, Scheers I, Waller MD, Sermet-Gaudelus I, Castellani C; ECFS Diagnostic Network Working Group.
J Cyst Fibros. 2024 Jul;23(4):590-602. doi: 10.1016/j.jcf.2024.03.008. Epub 2024 Mar 19.
Haber's syndrome.
McCormack CJ, Cowen P.
Australas J Dermatol. 1997 May;38(2):82-4. doi: 10.1111/j.1440-0960.1997.tb01113.x.
Palmoplantar keratodermas.
Itin PH, Fistarol SK.
Clin Dermatol. 2005 Jan-Feb;23(1):15-22. doi: 10.1016/j.clindermatol.2004.09.005.
Greither's disease.
Athanikar SB, Inamadar AC, Palit A, Sampagavi VV, Deshmukh NS.
Indian J Dermatol Venereol Leprol. 2003 Jul-Aug;69(4):292-3.
Pityriasis Rubra Pilaris.
Greiling TM, Brown F, Syed HA.
2024 Apr 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
[Palmoplantar keratosis].
Nagai H, Emi M.
Nihon Rinsho. 2000 Jul;58(7):1501-4.
Papillon-Lefèvre syndrome: Oral aspects and treatment.
Giannetti L, Apponi R, Dello Diago AM, Jafferany M, Goldust M, Sadoughifar R.
Dermatol Ther. 2020 May;33(3):e13336. doi: 10.1111/dth.13336. Epub 2020 Apr 9.
Nagashima-type palmoplantar keratosis: a common Asian type caused by SERPINB7 protease inhibitor deficiency.
Kubo A.
J Invest Dermatol. 2014 Aug;134(8):2076-2079. doi: 10.1038/jid.2014.156.
